MoscaLBenjaminEJBerraKet al.Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: A guideline from the American Heart Association. J Am Coll Cardiol2011; 57: 1404–1423.
2.
RobertsonRM. Women and cardiovascular disease: The risks of misperception and the need for action. Circulation2001; 103: 2318–2320.
3.
SanghaviMKulinskiJAyersCRet al.Association between number of live births and markers of subclinical atherosclerosis: The Dallas Heart Study. Eur J Prev Cardiol2016; 23: 391–399.
4.
LazdamMDavisEFLewandowskiAJet al.Prevention of vascular dysfunction after preeclampsia: A potential long-term outcome measure and an emerging goal for treatment. J Pregnancy2012; 2012: 704146–704146.
5.
HeidaKYBotsMLde GrootCJet al.Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline. Eur J Prev Cardiol2016; 23: 1863–1879.
6.
LazdamMde la HorraADieschJet al.Unique blood pressure characteristics in mother and offspring after early onset preeclampsia. Hypertension2012; 60: 1338–1345.
7.
PetersSAvan der SchouwYTWoodAMet al.Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study. Eur J Prev Cardiol2016; 23: 1755–1765.
8.
Le-HaCBeilinLJBurrowsSet al.Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence. Eur J Prev Cardiol2013; 20: 947–955.
9.
PiepoliMFHoesAWAgewallSet al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
10.
GlisicMShahzadSTsoliSet al.Association between progestin-only contraceptive use and cardio-metabolic outcomes: A systematic review and meta-analysis. Eur J Prev Cardiol2018; 25: 1042–1052.
11.
KimCSeidelKWBegierEAet al.Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch Intern Med2001; 161: 1766–1771.